| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.70B | 37.18B | 36.18B | 35.98B | 32.25B | 29.06B |
| Gross Profit | 7.76B | 8.98B | 9.71B | 9.85B | 8.37B | 8.39B |
| EBITDA | 5.25B | 5.38B | 7.12B | 7.40B | 6.24B | 7.35B |
| Net Income | 1.37B | 1.86B | 3.76B | 4.12B | 3.28B | 4.20B |
Balance Sheet | ||||||
| Total Assets | 32.23B | 32.02B | 31.34B | 29.45B | 27.98B | 31.39B |
| Cash, Cash Equivalents and Short-Term Investments | 3.60B | 3.47B | 3.54B | 3.95B | 3.18B | 6.62B |
| Total Debt | 33.52B | 26.61B | 25.80B | 24.60B | 23.80B | 23.61B |
| Total Liabilities | 40.61B | 40.11B | 38.78B | 37.43B | 36.68B | 36.71B |
| Stockholders Equity | -8.39B | -8.10B | -7.45B | -7.99B | -8.71B | -5.32B |
Cash Flow | ||||||
| Free Cash Flow | 2.34B | 2.44B | 3.32B | 3.68B | 2.56B | 4.52B |
| Operating Cash Flow | 4.27B | 4.75B | 6.10B | 6.01B | 4.40B | 5.99B |
| Investing Cash Flow | -1.95B | -2.49B | -2.70B | -2.27B | -2.15B | -319.50M |
| Financing Cash Flow | -2.29B | -2.30B | -3.72B | -2.99B | -5.64B | -3.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $221.43B | 25.46 | -336.89% | 2.31% | 1.26% | 2.87% | |
74 Outperform | $44.00B | 26.98 | -20.57% | 1.84% | 11.60% | -4.33% | |
71 Outperform | $23.22B | 20.24 | 50.71% | 3.06% | 8.61% | 9.39% | |
67 Neutral | $42.33B | 32.22 | 47.00% | ― | 7.31% | 5.26% | |
64 Neutral | $33.24B | 50.42 | 23.08% | 3.60% | 16.82% | -29.91% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $105.61B | 83.00 | -17.22% | 2.88% | 2.80% | -50.71% |